Port delivery system with ranibizumab vs monitoring in nonproliferative diabetic retinopathy without macular edema: the pavilion randomized clinical trial
Pieramici DJ, Awh CC, Chang M, et al.
JAMA Ophthalmol. 2025:e250001.
Leggi
Differential effects of type 2 diabetes and gestational diabetes on maternal and cord blood adipokines and newborn weight
Gruber BL, Rawal Y, Irabor P, et al.
BMC Pregnancy Childbirth. 2025;25(1):238.
Leggi
Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: a target trial emulation study
Ju C, Xiong X, Lui DTW, et al.
Diabetes Res Clin Pract. 2025:112082.
Leggi
Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes
Tsoi AT, Sng J, Tummanapalli SS, et al.
Diabetologia. Pub. online 7 Mar 2025.
Leggi
Multivitamins after myocardial infarction in patients with diabetes: a randomized clinical trial
Ujueta F, Lamas GA, Anstrom KJ, et al.
JAMA Intern Med. 2025:e248408.
Leggi
The impact of sodium-glucose cotransporter-2 inhibitors on atrial fibrillation burden in diabetic patients
Kidess GG, Hamza M, Goru R, et al.
Am J Cardiol. Pub. online 7 Mar 2025.
Leggi
OCCHIO AL TRIAL AMD: DOPPIO APPUNTAMENTO 20 E 27 MARZO
Carissimi Soci, doppio appuntamento a marzo con gli approfondimenti Occhio al Trial AMD. Ci troveremo il 20 e il 27 marzo alle ore 18.00 per due nuove dirette: 20.03 "MAESTRO-NASH: il trial di fase 3 che consacra il Resmetirom come primo trattamento per la steatoepatite associata a disfunzione metabolica" Angelo…
Leggi
